News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW. 

This week in DDW, researchers have made a key discovery into cancer survival. Elsewhere, a global research effort into kidney disease is underway. 

The top stories: 

 

Researchers identify RNA linked to cancer survival

 

Researchers at the Texas A&M University Health Science Center have identified a novel RNA molecule that plays a crucial role in preserving the integrity of a key cellular structure, nucleolus. 

Read more… 

 

US Senate reauthorises Priority Review Voucher scheme  


The US Senate has reauthorised the US Food and Drug Administration (FDA)’s Priority Review Voucher (PRV), helping biotech companies to develop rare disease drugs. 

Read more… 

 

 

Global research launched into early diabetic kidney disease 


Pharma innovation hub BioMed X has partnered with the government of Barbados to launch global research into a therapy for early diabetic kidney disease.  

Read more… 

 

UK must develop better pre-clinical model, ABPI warns  


The Association of the British Pharmaceutical Industry (ABPI) has urged scientists to develop better pre-clinical models to accelerate the development of new medicines.
 

Read more… 

 

 

UK Chancellor hails FUJIFILM’s biomanufacturing expansion 


UK chancellor Rachel Reeves has hailed the expansion of FUJIFILM Biotechnologies facilities as “a vote of confidence in the UK”. 
 

Read more…